Analysts have been eager to weigh in on the Healthcare sector with new ratings on Veracyte (VCYT – Research Report) and Argenx Se (ARGX – Research Report).
Argenx Se (ARGX)
In a report released today, Xian Deng from UBS maintained a Hold rating on Argenx Se, with a price target of $410.00. The company’s shares closed last Thursday at $382.55.
Deng has an average return of
According to TipRanks.com, Deng is ranked #719 out of 8834 analysts.
Currently, the analyst consensus on Argenx Se is a Moderate Buy with an average price target of $471.94.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on VCYT:
